University:
West Coast University
Course:
NURS 180 | Pharmacology
Academic year:

2021
Views:

430

Pages:

1
Author:

folclord7m

ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME _____________________________________ Apixaban ( Eliquis) MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ anticoagulants CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Acts as a selective, reversible site inhibitor of factor Xa, inhibiting both free and bound factor. Does not affect platelet aggregation directly, but does inhibit thrombin-induced platelet aggregation. Therapeutic Use Treatment and prevention of thromboembolic events. Complications Bleeding and hypersensitivity reactions including anaphylaxis Medication Administration PO!(Adults):!5 mg twice daily;!!Any 2 of the following: age ≥80 yr, weight ≤60 kg, serum creatinine ≥1.5 mg/dLÐ !2.5 mg twice daily;!! Contraindications/Precautions Previous severe hypersensitivity reactions; Active pathological bleeding; Severe hepatic impairment; Interactions !Increase risk of bleeding with other!anticoagulants,!aspirin,!clopidogrel,!ticagrelor,!p rasugrel,!Þbrinolytics,!NSAIDs,!SNRIs, or !SSRIs. Nursing Interventions Assess patient for symptoms of stroke, DVT, PE, bleeding, or peripheral vascular disease periodically during therapy. Client Education Evaluation of Medication Effectiveness Reduction in the risk and treatment of stroke and systemic embolism. ACTIVE LEARNING TEMPLATES Instruct patient to take apixaban as directed. Take missed doses as soon as remembered on the same day and resume twice daily administration; do not double doses. THERAPEUTIC PROCEDURE A7